Back to Trades
Gano Kyle
Chief Executive OfficerDirectorCIK 0001567160
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 3
- Buy transactions
- 0
- Sell transactions
- 2
- Companies
- 1
- Active
- 2026
Gano Kyle, Chief Executive Officer, Director, has filed 3 SEC reports (2026), all concentrated in NEUROCRINE BIOSCIENCES INC (NBIX), totaling $23.2M in disclosed volume. Weighing $0 bought versus $4.8M sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
3 loaded
3 filings